SecBot SecBot
144 ·Filed Jun 11, 2026

ANAB

ANAPTYSBIO, INC
BEARISH
Impact 6/10
Horizonweeks Processed5mo ago SEC0001950047-26-005960
Form 144, notice of proposed sale of securities
Actionable Insight ▼ Bearish

The sustained insider selling by a top officer at a rate of ~$1M/week is a strong negative signal, especially given the stock's high valuation and bullish analyst consensus. Monitor for Form 4 filings to confirm actual sales and watch for any material news that could explain the selling.

DirectionBearish
Confidencehigh
Horizonweeks

How the stock moved after the report

BEARISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$56.07
T+0 close · Jun 11, 2026 · via day close
Latest settled
+0.95%
T+60 · $56.60
Vs SPY
−2.32%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 12 $56.07entry
  2. T+1 · 5mo ago +6.14%α +4.37% · $59.51
  3. T+5 · 5mo ago +2.57%α +1.90% · $57.51
  4. T+20 · 4mo ago +18.41%α +16.63% · $66.39
  5. T+60 · 2mo ago +0.95%α −2.32% · $56.60
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Dennis Mulroy, an officer of AnaptysBio, filed a Form 144 notice of intent to sell 35,000 common shares valued at approximately $1.85 million, to be executed through Morgan Stanley. The filing also reveals a heavy pattern of insider selling: Mulroy has sold over 260,000 shares in the past three weeks (May 15–June 10), totaling about $13.4 million, all via open-market sales after stock option exercises. This sustained selling by a top officer ahead of any public catalyst is a significant bearish signal.

Key Facts

  • Officer Dennis Mulroy filed Form 144 to sell 35,000 shares (~$1.85M) on June 11, 2026.
  • The filing reveals 18 prior open-market sales between May 15 and June 10, 2026, totaling ~260,000 shares and ~$13.4M.
  • All sales were executed after stock option exercises, indicating a systematic plan to monetize equity.
  • AnaptysBio has a $1.5B market cap and 94% analyst bullish consensus, making the insider selling pattern particularly notable.

Financial Impact

Officer sold ~$13.4M in shares over 3 weeks, with an additional $1.85M proposed; total ~$15.3M in planned sales.

insider selling volumedilution from option exercises

Risk Factors

  • Insider selling may indicate undisclosed negative developments (e.g., clinical trial setbacks, regulatory delays).
  • Heavy option exercise and sale pattern could pressure the stock if selling continues.
  • The 144 filing is an intent to sell; if the insider does not execute, the signal may be less severe.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
94% bullish (17 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-005960
Document: 0001950047-26-005960-index.html0001950047-26-005960
Document: 0001950047-26-005960.txt0001950047-26-005960

Track record

28 reports on ANAB

Performance horizon

10 of 18 bullish or bearish reports moved the stock their way by T+1. Best: +41.26% at T+60 after the Mar 3, 2026 report. 13 of 18 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $46.25 Now $45.73 −1.12% settles Nov 17
  2. Nov 12, 20264d ago Press Release Bearish 4/10 Entry $46.25 to $45.73 Now $45.73 +1.12% ▲ +1.12% −0.79% vs SPY
  3. Nov 6, 202610d ago Institutional Cluster Neutral 2/10 Entry $46.45 to $47.97 Now $45.73 −1.55% ▲ +3.27% +0.91% vs SPY
  4. Sep 21, 20268w ago Press Release Neutral 5/10 Entry $53.92 to $50.77 Now $45.73 −15.19% ▼ −5.84% −5.12% vs SPY
  5. Aug 12, 202613w ago Institutional Cluster Bullish 5/10 Entry $56.02 to $58.47 Now $45.73 −18.37% ▲ +4.37% +4.57% vs SPY
  6. Jun 29, 202620w ago 144 Bearish 6/10 Entry $67.50 to $65.43 Now $45.73 +32.25% ▲ +3.07% +2.93% vs SPY
  7. Jun 29, 202620w ago DEFA14A Neutral 2/10 Entry $67.50 to $65.43 Now $45.73 −32.25% ▼ −3.07% −2.93% vs SPY
  8. Jun 26, 202620w ago 144 Bearish 6/10 Entry $65.97 to $67.50 Now $45.73 +30.68% ▼ −2.32% −1.54% vs SPY
  9. Jun 22, 202621w ago 8-K Neutral 2/10 Entry $59.43 to $58.48 Now $45.73 −23.05% ▼ −1.60% −1.55% vs SPY
  10. Jun 17, 202621w ago 144 Bearish 5/10 Entry $57.51 to $59.99 Now $45.73 +20.48% ▼ −4.31% −4.63% vs SPY
Showing 10 of 28

US Market Status

Market Closed · Opens in 6h 34m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 11, 2026